Arqit snapped back from Monday's collapse while the pure-play qubit names gave ground and the enrichment-tech chokepoint kept sliding.

Tuesday's tape was governed by rates, not qubits — the 10-year Treasury yield hit 5.04%, its highest since 2007, ahead of the Federal Reserve's decision this week, and the Nasdaq closed off 0.8%. Against that, Arqit Quantum (ARQQ) topped the quantum board, up 12.2% to $18.27, but the move is best read as a rebound: the stock had cratered roughly 19% on Monday in the AI-safety selloff, and Tuesday recovered part of it with no fresh company catalyst. Arqit sits on the post-quantum-cryptography chokepoint — the quantum-safe key-distribution and encryption layer that has to be swapped in before scaled quantum machines break today's public-key crypto — a standards-and-security position distinct from the hardware names, and one that trades on sentiment more than on any single day's news.

The laggard was the isotope-enrichment chokepoint, and its move was a trend, not a shock. Silex Systems' ADR (SILXY) fell 5.2% to $15.41, a fourth straight down session with no dated catalyst behind it — a thin ADR unwinding. Silex's SILEX laser process is the same technology that enriches silicon-28 for the ultra-pure substrates spin-qubit roadmaps depend on (and uranium on the nuclear side), so the sustained selling sits directly on a materials strait the quantum stack needs. MKS Inc. (MKSI) fell 3.2% on the vacuum-and-photonics-subsystems rung, the other enabling-hardware name to give ground.

The tell of the session was that the pure-play qubit tier lagged even as the broad AI-silicon complex rebounded: IonQ (IONQ) −1.2%, Rigetti (RGTI) −1.2%, D-Wave (QBTS) −2.5% and Quantum Computing (QUBT) −1.6% all gave back, the rate move outweighing any read-through from the chip bounce. The green clustered instead in the enabling-instruments and photonics rung, riding the same life-science-tools bid that lifted the pharma complex: Bruker (BRKR) +5.9% and Agilent (A) +2.4% on measurement and metrology, with AMD (AMD) +2.2% and Coherent (COHR) +1.8% on the compute-and-optics layer. The chokepoints that supply the machines outperformed the machines.

The near catalysts are legislative and programmatic. The National Quantum Initiative Reauthorization Act (H.R. 8462 / S. 3597) is targeted for floor votes by month-end, the funding backbone for the whole domestic effort. ASP Isotopes (ASPI) has guided its first commercial silicon-28 shipments to Q3, i.e. by Sept 30 — a direct print on the enrichment chokepoint SILXY also maps. Further out, DARPA's Quantum Benchmarking Initiative moves from Stage B to a Stage C downselect across November and December, and Q2B26 Chicago (Dec 8–10) is the next industry set-piece. The Fed's decision this week sets the rate backdrop these long-duration names live and die on.